Genomics and Allergic Problems

Published Online: Monday, March 10, 2014
Follow Pharmacy_Times:
In this podcast, Osamu Ohara, PhD, of the laboratory of immunogenetics at RIKEN Research Center for Allergy and Immunology in Kanagawa, Japan, talks about the potential of functional genomics in the treatment of allergic diseases.

To listen to this podcast, click here.
Related Articles
An OTC allergy medication may be able to kill the bacteria behind Lyme disease, bringing researchers closer to developing the first targeted therapy for the debilitating infection.
Wockhardt USA LLC introduces its newest private label, OTC medication Fexofenadine in a small, easy-to-swallow tablet for next year’s fall allergy season.
The majority of patients who require inhalers for asthma or epinephrine autoinjectors for allergic disease for do not use the devices properly.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$